X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4517) 4517
Publication (262) 262
Book Review (33) 33
Magazine Article (11) 11
Book Chapter (10) 10
Newsletter (10) 10
Conference Proceeding (3) 3
Newspaper Article (3) 3
Data Set (2) 2
Book / eBook (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2771) 2771
mannitol - therapeutic use (2013) 2013
male (1572) 1572
mannitol (1503) 1503
index medicus (1379) 1379
female (1293) 1293
animals (1216) 1216
pharmacology & pharmacy (925) 925
adult (895) 895
middle aged (811) 811
mannitol - administration & dosage (559) 559
aged (510) 510
rats (473) 473
mannitol - chemistry (467) 467
mannitol - pharmacology (446) 446
surgery (393) 393
adolescent (345) 345
time factors (333) 333
permeability (293) 293
analysis (290) 290
child (287) 287
diuretics, osmotic - therapeutic use (287) 287
treatment outcome (271) 271
chemistry, multidisciplinary (266) 266
particle size (251) 251
intracranial pressure (228) 228
immunology (227) 227
excipients - chemistry (221) 221
osmolar concentration (208) 208
dogs (207) 207
clinical neurology (202) 202
powders (197) 197
brain edema - drug therapy (196) 196
chemistry, medicinal (194) 194
pharmacy (189) 189
saline solution, hypertonic - therapeutic use (188) 188
hypertonic saline (187) 187
mice (184) 184
transplantation (183) 183
administration, inhalation (174) 174
mannitol - metabolism (171) 171
child, preschool (170) 170
furosemide - therapeutic use (165) 165
diuretics - therapeutic use (164) 164
biochemistry, general (163) 163
mannitol - adverse effects (161) 161
intracranial pressure - drug effects (160) 160
pharmacology/toxicology (160) 160
respiratory system (155) 155
brain edema - etiology (152) 152
chemistry, pharmaceutical (152) 152
crystallization (151) 151
drug delivery systems (148) 148
mannitol - pharmacokinetics (148) 148
biomedicine (147) 147
care and treatment (147) 147
solubility (147) 147
prospective studies (145) 145
infant (141) 141
brain (140) 140
research article (138) 138
dose-response relationship, drug (137) 137
research (135) 135
drugs (132) 132
neurosciences (130) 130
retrospective studies (130) 130
in-vitro (129) 129
freeze drying (128) 128
rats, sprague-dawley (128) 128
health aspects (127) 127
critical care medicine (126) 126
temperature (126) 126
article (125) 125
dexamethasone - therapeutic use (123) 123
glucose (123) 123
rabbits (123) 123
mannitol - analogs & derivatives (122) 122
proteins (121) 121
pediatrics (116) 116
pressure (116) 116
acute kidney injury - prevention & control (115) 115
drug therapy, combination (115) 115
drug-delivery (114) 114
stability (113) 113
glucose - therapeutic use (112) 112
ischemia (112) 112
medicine, research & experimental (112) 112
blood-brain barrier (111) 111
injections, intravenous (111) 111
young adult (110) 110
disease models, animal (109) 109
technology, pharmaceutical - methods (109) 109
absorption (108) 108
acute disease (108) 108
delivery (108) 108
glycerol - therapeutic use (107) 107
in vitro techniques (106) 106
medicine & public health (105) 105
rats, wistar (105) 105
chemistry, pharmaceutical - methods (104) 104
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3959) 3959
German (157) 157
French (100) 100
Japanese (97) 97
Russian (84) 84
Italian (74) 74
Spanish (33) 33
Chinese (28) 28
Polish (27) 27
Hungarian (16) 16
Romanian (14) 14
Portuguese (7) 7
Bulgarian (4) 4
Czech (4) 4
Danish (4) 4
Dutch (4) 4
Serbian (3) 3
Slovak (3) 3
Croatian (2) 2
Finnish (2) 2
Hebrew (2) 2
Swedish (2) 2
Ukrainian (2) 2
Lithuanian (1) 1
Norwegian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Plastic and Reconstructive Surgery, ISSN 0032-1052, 09/2006, Volume 118, Issue 3, pp. 7S - 14S
The demand for safe, effective, long-lasting, biocompatible dermal filler materials is increasing. Many products that include synthetic polymers and autologous... 
SURGERY | SOFT-TISSUE AUGMENTATION | INJECTABLE HYALURONIC-ACID | COSMETIC SURGERY | GRANULOMATOUS REACTION | FACIAL LIPOATROPHY | OPEN-LABEL | INJECTIONS | SILICONE | ADVERSE-REACTIONS | PMMA-MICROSPHERES | Polymers - administration & dosage | Cellulose - therapeutic use | Humans | Transplantation, Autologous | Foreign-Body Reaction - prevention & control | Silicones - administration & dosage | Skin Aging | Cellulose - administration & dosage | Microspheres | Polymers - therapeutic use | Polymethyl Methacrylate - adverse effects | Cattle | Hydrogels - administration & dosage | Injections, Subcutaneous | Cellulose - adverse effects | Polymers - adverse effects | Lactic Acid - administration & dosage | Subcutaneous Tissue - pathology | Mannitol - adverse effects | Mannitol - therapeutic use | Rejuvenation | Silicones - adverse effects | Silicones - therapeutic use | Polymethyl Methacrylate - therapeutic use | Acrylic Resins - therapeutic use | Animals | Acrylic Resins - adverse effects | Acrylic Resins - administration & dosage | Mannitol - administration & dosage | Hydrogels - adverse effects | Lactic Acid - adverse effects | Durapatite - therapeutic use | Biocompatible Materials - administration & dosage | Biocompatible Materials - therapeutic use | Adipose Tissue - transplantation | Durapatite - adverse effects | Lactic Acid - therapeutic use | Biocompatible Materials - adverse effects | Hydrogels - therapeutic use | Foreign-Body Reaction - etiology | Reconstructive Surgical Procedures
Journal Article
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2013, Volume 32, Issue 6, pp. 633 - 640
Background The cardioprotective efficacy of erythropoietin (EPO) has been widely documented in rodent models of acute coronary syndrome. We sought to evaluate... 
Surgery | heart transplantation | heart preservation | Celsior solution | glyceryl trinitrate | zoniporide | ischemia–reperfusion injury | erythropoietin | ischemia-reperfusion injury | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | REPERFUSION INJURY | AKT | MODEL | PROTECTS | CARIPORIDE | TRANSPLANTATION | IN-VITRO | INHIBITION | RESPIRATORY SYSTEM | CARDIOPROTECTION | ISCHEMIA/REPERFUSION | SIGNAL TRANSDUCER | Erythropoietin - pharmacology | Electrolytes - therapeutic use | Glutamates - therapeutic use | Histidine - pharmacology | Pyrazoles - therapeutic use | Rats, Wistar | Recovery of Function - drug effects | Erythropoietin - therapeutic use | Guanidines - pharmacology | Male | Cold Ischemia | Histidine - therapeutic use | Nitroglycerin - pharmacology | Mannitol - pharmacology | Dose-Response Relationship, Drug | Disaccharides - pharmacology | Heart Rate - drug effects | Glutathione - pharmacology | Myocardial Reperfusion Injury - pathology | Cardioplegic Solutions - therapeutic use | Heart Rate - physiology | Recovery of Function - physiology | Models, Animal | Disaccharides - therapeutic use | Drug Therapy, Combination | Pyrazoles - pharmacology | Glutathione - therapeutic use | Mannitol - therapeutic use | Nitroglycerin - therapeutic use | Rats | Cardioplegic Solutions - pharmacology | Treatment Outcome | Myocardial Reperfusion Injury - physiopathology | Animals | Glutamates - pharmacology | Electrolytes - pharmacology | Hypothermia - physiopathology | Guanidines - therapeutic use | Myocardial Reperfusion Injury - prevention & control | Erythropoietin | Ischemia | Coronary heart disease
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2007, Volume 104, Issue 21, pp. 8947 - 8952
The use of recombinant tumor antigen proteins is a realistic approach for the development of generic cancer vaccines, but the potential of this type of... 
T lymphocytes | Cancer vaccines | Antigens | Cross priming | B lymphocytes | Plasmids | Vaccination | Melanoma | Antibodies | Tumors | Cancer vaccine | PLASMACYTOID DENDRITIC CELLS | B-CELLS | IMMUNIZATION | CANCER-PATIENTS | EPITOPE | cancer vaccine | CANCER/TESTIS ANTIGENS | IMMUNE-RESPONSES | DNA | MULTIDISCIPLINARY SCIENCES | IDENTIFICATION | TUMOR-ANTIGEN | Recombinant Proteins - therapeutic use | Mannitol - blood | Humans | Membrane Proteins - adverse effects | Epitopes, B-Lymphocyte - immunology | Membrane Proteins - therapeutic use | Recombinant Proteins - adverse effects | Th1 Cells - immunology | Oleic Acids - blood | Oligodeoxyribonucleotides - blood | Antigens, Neoplasm - therapeutic use | Antigens, Neoplasm - blood | Antibodies - immunology | Oligodeoxyribonucleotides - adverse effects | Antigens, Neoplasm - adverse effects | Oleic Acids - adverse effects | Membrane Proteins - blood | Oligodeoxyribonucleotides - therapeutic use | Mannitol - adverse effects | Oligodeoxyribonucleotides - immunology | Antigens, Neoplasm - immunology | Oleic Acids - therapeutic use | Mannitol - therapeutic use | Membrane Proteins - immunology | Immunotherapy - adverse effects | Mannitol - analogs & derivatives | Neoplasms - drug therapy | Recombinant Proteins - blood | Cancer Vaccines - immunology | Cross-Priming - immunology | Recombinant Proteins - immunology | Mannitol - immunology | CD8-Positive T-Lymphocytes - immunology | Neoplasms - pathology | Oleic Acids - immunology | Research | T cells | Tumor antigens | Biological Sciences
Journal Article
Respirology, ISSN 1323-7799, 08/2017, Volume 22, Issue 6, pp. 1084 - 1092
ABSTRACT Inhaled mucoactive agents are used in respiratory disease to improve mucus properties and enhance secretion clearance. The effect of mannitol,... 
expectorants | lung diseases | sputum | respiratory function tests | humans | ISOTONIC SALINE | DRY POWDER MANNITOL | CLEARANCE | SAFETY | ACETYLCYSTEINE-ISOPROTERENOL | INHALATION | BRONCHIECTASIS | SALINE-ISOPROTERENOL | OBSTRUCTIVE PULMONARY-DISEASE | RESPIRATORY SYSTEM | TERBUTALINE | Recombinant Proteins - therapeutic use | Humans | Deoxyribonuclease I - therapeutic use | Mesna - therapeutic use | Lung Diseases - drug therapy | Mannitol - pharmacology | Mucociliary Clearance - drug effects | Symptom Flare Up | Forced Expiratory Volume | Expectorants - therapeutic use | Deoxyribonuclease I - pharmacology | Saline Solution, Hypertonic - therapeutic use | Acetylcysteine - therapeutic use | Bronchiectasis - drug therapy | Mannitol - therapeutic use | Administration, Inhalation | Saline Solution, Hypertonic - pharmacology | Recombinant Proteins - pharmacology | Vital Capacity | Acetylcysteine - pharmacology | Quality of Life | Expectorants - pharmacology | Lung Diseases - physiopathology | Bronchiectasis - physiopathology | Chronic Disease | Cystic fibrosis | Respiratory agents | Pulmonary function tests | Drug therapy | Analysis | Deoxyribonuclease | Secretion | Lung diseases | Acetylcysteine | Mucus | Bronchiectasis | Cough | Asthma | Quality of life | Bronchospasm | Side effects | Respiratory diseases | Sputum | Mannitol | Chronic obstructive pulmonary disease
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 02/2010, Volume 126, Issue 4, pp. 909 - 918
Journal Article